Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
- May -
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
- 2009 -
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
May 2009 - 77 products
IP
CI
Risperidon Sandoz 0,5 mg
28 Tablet(s)
7.52
16.85
10 %
Melting tablets: Risperidonum
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 1 mg
28 Tablet(s)
12.35
26.50
10 %
Melting tablets: Risperidonum 1 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 2 mg
28 Tablet(s)
20.26
39.70
10 %
Melting tablets: Risperidonum 2 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 3 mg
28 Tablet(s)
30.75
51.75
10 %
Melting tablets: Risperidonum 3 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 4 mg
28 Tablet(s)
37.49
59.50
10 %
Melting tablets: Risperidonum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Irinotecan-Teva liquid 40
mg/2 ml
38.11
60.20
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 40mg / 2ml
Teva Pharma AG
A / SL / SG
FB
G
IP
Irinotecan-Teva liquid 100
mg/5 ml
91.42
121.45
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 100mg / 5ml
Teva Pharma AG
A / SL / SG
FB
G
IP
Irinotecan-Teva liquid 500
mg/25 ml
357.73
427.50
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 500mg / 25ml
Teva Pharma AG
A / SL / SG
FB
G
IP
Irinotecan-Teva liquid 300
mg/15 ml
245.64
298.70
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 300mg / 15ml
Teva Pharma AG
A / SL / SG
FB
G
IP
CI
Budesonid Sandoz 64
120 unidose(s)
7.95
17.35
10 %
Nasal spray: Budesonidum 64 µg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Bicalutamid-Teva 50 mg
30 Tablet(s)
75.98
103.75
10 %
Coated tablets: Bicalutamidum 50 mg
Teva Pharma AG
B / SL / SG
FB
G
IP
CI
Bicalutamid-Teva 50 mg
100 Tablet(s)
159.23
199.40
10 %
Coated tablets: Bicalutamidum 50 mg
Teva Pharma AG
B / SL / SG
FB
G
IP
CI
Bicalutamid-Teva 150 mg
30 Tablet(s)
138.16
175.20
10 %
Coated tablets: Bicalutamidum 150 mg
Teva Pharma AG
B / SL / SG
FB
G
IP
CI
Bicalutamid-Teva 150 mg
100 Tablet(s)
292.13
352.10
10 %
Coated tablets: Bicalutamidum 150 mg
Teva Pharma AG
B / SL / SG
FB
G
IP
CI
Cefuroxim axapharm 250 mg
14 Tablet(s)
9.15
18.70
10 %
Coated tablets: Cefuroximum 250 mg
axapharm ag
A / SL / SG
FB
G
IP
CI
Cefuroxim axapharm 500 mg
14 Tablet(s)
15.00
33.65
10 %
Coated tablets: Cefuroximum 500 mg
axapharm ag
A / SL / SG
FB
G
IP
CI
Indapamid Spirig HC
Retard
30
2.98
7.55
10 %
Coated tablets: Indapamidum 1.5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Indapamid Spirig HC
Retard
90
7.25
16.55
10 %
Coated tablets: Indapamidum 1.5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Losartan-HCT-Mepha 50
mg/12.5 mg
28 Tablet(s)
10.22
19.95
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Losartan-HCT-Mepha 50
mg/12.5 mg
98 Tablet(s)
32.97
54.30
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Losartan-HCT-Mepha 100
mg/12.5 mg
28 Tablet(s)
12.74
26.95
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Losartan-HCT-Mepha 100
mg/12.5 mg
98 Tablet(s)
44.41
67.45
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Losartan-HCT-Mepha 100
mg/25 mg
28 Tablet(s)
12.74
26.95
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Losartan-HCT-Mepha 100
mg/25 mg
98 Tablet(s)
44.41
67.45
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Itraconazol Axapharm
‐
I
4 Capsule(s)
5.48
14.50
10 %
Capsules: Itraconazolum 100 mg
axapharm ag
B / SL / SG
FB
G
IP
CI
Itraconazol Axapharm
15 Capsule(s)
18.52
37.70
10 %
Capsules: Itraconazolum 100 mg
axapharm ag
B / SL / SG
FB
G
IP
CI
Itraconazol Axapharm
30 Capsule(s)
35.74
57.50
10 %
Capsules: Itraconazolum 100 mg
axapharm ag
B / SL / SG
FB
G
IP
CI
Amlodipin Spirig HC 5mg
30 Tablet(s)
6.56
15.75
10 %
Tablets: Amlodipinum 5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Amlodipin Spirig HC 5mg
100 Tablet(s)
17.86
36.95
10 %
Tablets: Amlodipinum 5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Amlodipin Spirig HC 10mg
30 Tablet(s)
9.23
18.80
10 %
Tablets: Amlodipinum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Amlodipin Spirig HC 10mg
100 Tablet(s)
35.16
56.80
10 %
Tablets: Amlodipinum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Perindopril Sandoz 2 mg
30 Tablet(s)
6.50
15.70
10 %
Tablets: Tert-Butylamini Perindoprilum 2 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Perindopril Sandoz 2 mg
90 Tablet(s)
19.20
38.50
10 %
Tablets: Tert-Butylamini Perindoprilum 2 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Perindopril Sandoz 4 mg
30 Tablet(s)
10.90
20.75
10 %
Tablets: Tert-Butylamini Perindoprilum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Perindopril Sandoz 4 mg
90 Tablet(s)
20.82
40.35
10 %
Tablets: Tert-Butylamini Perindoprilum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Perindopril Sandoz 8 mg
30 Tablet(s)
12.80
27.00
10 %
Tablets: Tert-Butylamini Perindoprilum 8 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Perindopril Sandoz 8 mg
90 Tablet(s)
24.26
44.30
10 %
Tablets: Tert-Butylamini Perindoprilum 8 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Torasemid-Mepha 200
20 Tablet(s)
12.61
26.80
10 %
Tablets: Torasemidum 200 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Torasemid-Mepha 200
100 Tablet(s)
57.86
82.90
10 %
Tablets: Torasemidum 200 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
PP
Bramitob
56 x 4 ml
2262.98
2545.90
10 %
Inhalation solution: Tobramycinum 300mg / 4ml
Chiesi SA
A / SL
FB
G
IP
CI
PP
Epiduo
45 g
20.27
39.70
10 %
Gel: 2 Active Agents
Galderma SA
B / SL
FB
G
IP
PP
Epiduo forte
45 g
20.27
39.70
10 %
Gel: 2 Active Agents
Galderma SA
B / SL
FB
G
L
IP
V/S
Rotarix liquid
1.5 ml
39.36
61.65
10 %
Suspension (oral): Rotavirus Humanus (Stamm: Rix4414) Min
GlaxoSmithKline AG
B / SL
FB
G
IP
Glucolyte Bioren
5 x 500 ml
PR
PR
k.A.
Infusion solution: 3 Active Agents
Sintetica SA
B
FB
G
IP
Glucolyte Bioren
4 x 1000 ml
PR
PR
k.A.
Infusion solution: 3 Active Agents
Sintetica SA
B
FB
G
IP
Glucolyte Bioren
10 x 500 ml
PR
PR
k.A.
Infusion solution: 3 Active Agents
Sintetica SA
B
FB
G
IP
Glucolyte Bioren
10 x 1000 ml
PR
PR
k.A.
Infusion solution: 3 Active Agents
Sintetica SA
B
FB
G
IP
Ringer lactate sans
potassium Bioren
4 x 1000 ml
PR
PR
k.A.
Infusion solution: 4 Active Agents
Sintetica SA
B
FB
G
IP
Ringer lactate sans
potassium Bioren
10 x 1000 ml
PR
PR
k.A.
Infusion solution: 4 Active Agents
Sintetica SA
B
FB
G
IP
Aminophyllin Amino
10 x 10 ml
PR
PR
k.A.
Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte
● 
B
FB
G
IP
Natrium Bicarbonicum
Sintetica 8,4 %
10 1 ampoule(s) à 2 ml
PR
PR
k.A.
Injection solution: Natrii Hydrogenocarbonas 84 mg/ml
Sintetica SA
B
FB
G
IP
A
Phenobarbital Bichsel 2 %
10 ampoule(s)
PR
PR
k.A.
Injection solution: Phenobarbitalum 20.5 mg/ml
Laboratorium Dr. G.
Bichsel AG
B
FB
G
IP
A
Phenobarbital Bichsel 2 %
100 ampoule(s)
PR
PR
k.A.
Injection solution: Phenobarbitalum 20.5 mg/ml
Laboratorium Dr. G.
Bichsel AG
B
FB
G
IP
A
Phenobarbital Bichsel 10 %
10 ampoule(s)
PR
PR
k.A.
Injection solution: Phenobarbitalum 200mg / 2ml
Laboratorium Dr. G.
Bichsel AG
B
FB
G
IP
A
Phenobarbital Bichsel 10 %
100 ampoule(s)
PR
PR
k.A.
Injection solution: Phenobarbitalum 200mg / 2ml
Laboratorium Dr. G.
Bichsel AG
B
FB
G
IP
CI
CM
Irotussin Antitussivum
200 ml
PR
PR
k.A.
Sirup: Dextromethorphanum 6.25mg / 5ml
Tentan AG
B
FB
G
IP
CI
Budesonid Sandoz 32
120 unidose(s)
4.29
9.00
k.A.
Nasal spray: Budesonidum 32 µg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
CM
Otriduo Schnupfen
15 ml
PR
PR
k.A.
Nasal spray: 2 Active Agents
Haleon Schweiz AG
D
FB
G
IP
CI
Levacin 100/25
30
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Acino Pharma AG
B
FB
G
IP
CI
Levacin 100/25
100
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Acino Pharma AG
B
FB
G
IP
CI
Levacin 200/50
30
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Acino Pharma AG
B
FB
G
IP
CI
Levacin 200/50
100
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Acino Pharma AG
B
FB
G
IP
CI
PP
Epiduo
30 g
13.94
28.30
k.A.
Gel: 2 Active Agents
Galderma SA
B
FB
G
IP
CI
PP
Epiduo
60 g
24.54
44.55
k.A.
Gel: 2 Active Agents
Galderma SA
B
FB
G
IP
PP
Epiduo forte
60 g
PR
PR
k.A.
Gel: 2 Active Agents
Galderma SA
B
FB
G
IP
CI
Finacapil
28 Tablet(s)
PR
PR
k.A.
Coated tablets: Finasteridum 1 mg
Sandoz
Pharmaceuticals AG
B / LPPV
FB
G
IP
CI
Finacapil
98 Tablet(s)
PR
PR
k.A.
Coated tablets: Finasteridum 1 mg
Sandoz
Pharmaceuticals AG
B / LPPV
FB
G
IP
V/S
Rotarix liquid
1.5 ml
PR
PR
k.A.
Suspension (oral): Rotavirus Humanus (Stamm: Rix4414) Min
GlaxoSmithKline AG
B
FB
G
CI
H
Circuvin homöopathische
Kreislauftropfen
50 ml
PR
PR
k.A.
Drops: 4 Active Agents
Herbamed AG
D
FB
G
IP
Natrium Chloratum
Sintetica 10 %
10 1 ampoule(s) à 10 ml
PR
PR
k.A.
concentrato di perfusione: Natrii Chloridum 100 mg/ml
Sintetica SA
B
FB
G
IP
Natrium Chloratum
Sintetica 20 %
10 1 ampoule(s) à 10 ml
PR
PR
k.A.
concentrato di perfusione: Natrii Chloridum 200 mg/ml
Sintetica SA
B
FB
G
IP
Natrium Chloratum
Sintetica 25 %
10 1 ampoule(s) à 10 ml
PR
PR
k.A.
concentrato di perfusione: Natrii Chloridum 250 mg/ml
Sintetica SA
B
FB
G
IP
V/S
PP
Optaflu
0.5 ml
10.05
19.70
k.A.
Vaccinum Influenzae Inactivatum ex Corticis Antigeniis Praeparatum (Cellulae Mdck) 2015/2016
Novartis Pharma
Schweiz AG
B
FB
G
IP
Ceftriaxon OrPha 1 g
1 g
11.50
25.50
k.A.
OrPha Swiss GmbH
A
FB
G
IP
Ceftriaxon OrPha 2 g
2 g
17.00
35.90
k.A.
OrPha Swiss GmbH
A
FB
G
IP
Ceftriaxon OrPha 1 g
5 x 1 g
PR
PR
k.A.
OrPha Swiss GmbH
A
FB
G
IP
Ceftriaxon OrPha 2 g
5 x 2 g
PR
PR
k.A.
OrPha Swiss GmbH
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home